title: What is "the matter" with restenosis in 2002?
authors.forename: J Eduardo
authors.initials: JE
authors.lastname: Sousa
authors.forename: Marco A
authors.initials: MA
authors.lastname: Costa
authors.forename: Amanda G M R
authors.initials: AG
authors.lastname: Sousa
mesh_terms: D023903:Coronary Restenosis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007249:Inflammation / Q000209:etiology / Q000517:prevention & control; D020123:Sirolimus / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects* / Q000639:trends
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus